Creotech Instruments (WAR:CRI) Research & Development: zł0.0 Mil (TTM As of Mar. 2026)


WAR:CRI Creotech Instruments SA WAR:CRI
73 GF Score
Price zł727.00
GF Value zł752.35
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Creotech Instruments Research & Development?

Creotech Instruments WAR:CRI -2.28% 73 Research & Development is zł0.0 Mil as of Mar. 2026. GuruFocus rates WAR:CRI with a GF Score™ of 73/100 and a GF Value™ of zł752.35 (Fairly Valued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Creotech Instruments's Research & Development for the three months ended in Mar. 2026 was zł0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was zł0.0 Mil.

Creotech Instruments  (WAR:CRI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Creotech Instruments Research & Development Related Terms

Creotech Instruments Research & Development Historical Data

* Premium members only.

The historical data trend for Creotech Instruments's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Creotech Instruments Research & Development Chart

Creotech Instruments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Creotech Instruments Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:CRI
73GF Score
Creotech Instruments SA WAR:CRI
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Creotech Instruments Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of zł0.0 Mil mean?
Creotech Instruments (WAR:CRI) has a Research & Development of zł0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Creotech Instruments and its competitors.
Is Creotech Instruments' Research & Development too high?
Creotech Instruments' current Research & Development is zł0.0 Mil. Overall, Creotech Instruments has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Creotech Instruments' Research & Development compare to GE and RTX?
Creotech Instruments' Research & Development of zł0.0 Mil can be compared against companies in the Aerospace & Defense industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Aerospace & Defense company?
A good Research & Development depends on the Aerospace & Defense industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Creotech Instruments and its competitors. Creotech Instruments's current Research & Development is zł0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creotech Instruments stock overvalued right now?
Based on GuruFocus' analysis, Creotech Instruments (WAR:CRI) is currently considered Fairly Valued. The stock's GF Value™ is zł752.35, compared to a current price of zł727.00 — trading 3.4% below its estimated fair value. The current Research & Development is zł0.0 Mil. Creotech Instruments' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Creotech Instruments (WAR:CRI), the current Research & Development is zł0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Creotech Instruments (WAR:CRI) Overvalued in 2026?

Based on GuruFocus' analysis, Creotech Instruments stock appears to be undervalued. The current stock price of zł727.00 is trading 3.4% below its estimated GF Value™ of zł752.35. GuruFocus considers Creotech Instruments to be Fairly Valued.

Key valuation signals for WAR:CRI:

  • Research & Development: zł0.0 Mil
  • GF Value™: zł752.35 vs. price of zł727.00 (3.4% below fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the WAR:CRI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Creotech Instruments Business Description

Other Exchanges 5OB:Germany
Address Gen. L. Okulickiego 7/9, Piaseczno, POL, 05-500
Creotech Instruments SA is a provider of advanced space technologies, specialized electronics, and hardware with global applications in areas such as quantum computers, quantum cryptography, quantum physics, and high energy physics laboratories. Its five primary business segments are: NewSpace dedicated to developing a satellite platform and its components; Earth Observation dedicated to developing Earth Observation systems and UAV technology (Unmanned Aerial Vehicle); Science dedicated to developing specialized electronics and components for quantum computers and time synchronization systems; Production dedicated to the manufacture of electronics; ESA Projects dedicated chiefly to projects carried in partnership with or/and commissioned by the European Space Agency (ESA).
73GF Score

Get the complete analysis for WAR:CRI

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł727.00
Price
zł752.35
GF Value